Heparin is an effective treatment for preventing liver failure after hepatectomy

Figure 2 Baseline and postoperative liver function and coagulation results before and after propensity score matching. A: Baseline total bilirubin levels in the heparin and non-heparin groups before propensity score matching (PSM); B: Baseline total bilirubin levels in the heparin and non-heparin groups after PSM; C: Baseline alanine transaminase (ALT) levels in the heparin and non-heparin groups before PSM; D: Baseline ALT levels in the heparin and non-heparin groups after PSM; E: Baseline aspartate transaminase (AST) levels in the heparin and non-heparin groups before PSM; F: Baseline AST levels in the heparin and non-heparin groups after PSM; G: Baseline international normalized ratio (INR) values in the heparin and non-heparin groups before PSM; H: Baseline INR values in the heparin and non-heparin groups after PSM; I: Baseline platelets (PLT) levels in the heparin and non-heparin groups before PSM; J: Baseline PLT levels in the heparin and non-heparin groups after PSM; K: Baseline prothrombin time (PT) levels in the heparin and non-heparin groups before PSM; L: Baseline PT levels in the heparin and non-heparin groups after PSM. ^aP < 0.05; ^bP < 0.01; ^cP < 0.001. PSM: Propensity score matching; AST: Aspartate transaminase; ALT: Alanine transaminase; INR: International normalized ratio; PLT: Platelets; PT: Prothrombin time.